Introduction
Bisphosphonates (e.g., pamidronate, etidronate, clodronate, alendronate, tiludronate, risedronate, and ibandronate) are established as effective treatments of osteoporosis for decades and shown to be effective in prevention of bone fracture [1] . Osteoporosis is a common type of bone disease characterised by reduced bone mass and increased in skeletal fragility [2] . Bisphosphonate acts by decreasing bone resorption, thereby slowing bone loss Objective: To understand the effects of combination treatment of pamidronate with isolated Quercus infectoria semi-purified fraction (QIsm-F) on human foetal osteoblast cell model (hFOB through reduce osteoclastic bone resorption [3, 4] . It possesses unique pharmacological character in which they have the potential to continue to affect bone metabolism long after discontinuance of its intake [5, 6] . Several research has reported possible side effects of bisphosphonate which can cause possible osteonecrosis of the jaw in oncology patients as well as atypical femoral fractures caused by over suppression of bone remodelling [7, 8] . Meanwhile, orally administering bisphosphonates has a very low bioavailability and may induce gastrointestinal disturbances [1] . These agents have little ability to stimulate new bone synthesis. Therefore, investigations of alternative agents that can improve synthesis of new bone are fairly significant.
Bone is a dynamic tissue that undergoes constant remodelling through bone formation and resorption. The process of bone remodelling comprised of sequential events triggered initially from resorption of existing bone by osteoclast followed by bone formation by osteoblast [9] . Thus, osteoblast is the key component in bone multicellular unit. Osteoblasts are differentiated from multipotent mesenchymal cells that are regulated by several cytokines which include bone morphogenetic proteins-2 (BMP-2), transforming growth factor-毬 and so on [10, 11] . The BMP-2 then faciliatates to differentiate mesenchymal cells with osteoblasts and induces bone formation by activating Smad signaling pathway and regulating transcription of osteoblast specific transcription factor such as Runtrelated transcription factor-2 (Runx2)/Core-binding factor-1, Osterix (Osx), alkaline phosphatase, type 栺 collagen, osteocalcin, and bone sialoprotein 2 [12, 13] .
Runx2 and Osx are osteoblast-specific transcription factors essential for the development of osteoblastic cells and bone formation [14, 15] .
The process of osteoblast differentiation is directed by Runx2 in which mesenchymal progenitor cells evolves to preosteoblast. Then, preosteoblastis directed to immature osteoblast by Runx2, Osx and 毬 -catenin [16] . On the other hand, Osx is the second transcription factor that is essential for osteoblast differentiation whereby it is specifically expressed in all developing bones [16, 17] . Given that these two transcription factors are essential for osteoblast differentiation from independent progenitor cells, the quantification of these factors could be used to determine the osteoblastogenic potential in discovery of new anabolic agent acting on bone [18] [19] [20] . Therefore, both Runx2 and Osx are important transcription factors for osteoblast differentiation and controlling the expressions of osteoblastogenic marker that are required for the terminal osteoblast differentiation and bone mineralisation [21] .
Quercus infectoria (Q. infectoria) Olivier (Fagaceae) is a small tree or a shrub mainly presented in Greece, Asia Minor, Syria and Iran [22] . The galls of Q. infectoria have a great medicinal value and have pharmacologically been deciphered to be astringent, ant diabetic, antitremorine, local anaesthetic, antipyretic and antiparkinsonian [23] . The main components of Q. infectoria comprise of 50% to 70% polyphenols, which is made up from abundance amount of tannins, gallic acid, syringic acid, ellagic acid, amentoflavone, hexamethyl ether, isocryptomerin, methyl betulate, methyl oleanate and hexagalloyl glucose [24] . Throughout the years, various study reported the effects of polyphenols on promoting the formation of new bone [25, 26] . Recently, polyphenols derived from dried plum have been reported to enhance osteoblast activity and function by upregulating Runx2, Osx and IGF-栺 expression [27] . In addition, our preliminary study has found that the level of alkaline phosphates in hFOB 1.19 increases significantly after being treated with Q. infectoria galls extract,providing initial insight on the ability of Q.
infectoria in modulating bone formation [28] . However, the effects of combining Q. infectoria with readily available osteoporotic agent such as biophosphonate have not been examined and understood.
In the present study, the paper aims to investigate and understand the effects of combining the readily available and commonly used osteoporotic drug (pamidronate) with Q. infectoria semi-purified fraction (QIsm-F) on human foetal osteoblast cell model (hFOB 1.19 cell line) by assessing the levels and expression of Osx and Runx2 important osteoblastogenic marker.
Materials and methods

Extraction of Q. infectoria extract
Q. infectoria galls were obtained from local market. The galls were identified based on its morphology parameters such as external colour, size, surface, texture, odour, taste and thickness [29] . Aqueous extraction of Q. infectoria was done by grinding the Q. infectoria galls to obtain powdered form followed by weighing 50 g of crude Q. infectoria extract in 100 mL of sterile distilled water and refluxing in water bath at 50 曟 for 24 h. The fraction with the same R f value will again be pooled together and considered as final semi-purified product [30] . The presence of polyphenols is confirmed by performing ferric chloride (Fecl 3 ) staining on thin layer chromatography plate and comparing to the standard.
Isolation and fractionation of QIsm-F
Cell culture conditions
Human foetal osteoblast cell, hFOB 1.19 (CRL-11372) was purchased from American Type Cell Culture (Manassas, USA).
The cells were revived in Dulbecco's Modified Eagle Medium F-12 (Gibco, USA) and supplemented with 10% fetal bovine serum; (Gibco, USA) and 1% penicillin-streptomycin (Gibco, USA). The cells were incubated in 5% CO 2 incubator at 37 曟 . All cell culture work was maintained in a sterile condition by applying aseptic technique and being carried out in the Bio safety cabinet class 2 (ESCO, Singapore).
Cell viability assay/MTT assay
This study employs pamidronate as osteoporotic control drug and agent for treatment combination with QIsm-F. Meanwhile, tamoxifen, a type of selective estrogen receptor, on the other hand, was established as negative control drug due to its known negative effect on osteoblast cell [31, 32] and untreated control was used as general control. hFOB 1.19 cells were plated in 96-well plate at a density 5伊10 3 cells per well [33] . Twenty four hour after plating, the cells were exposed with different concentration of each treatment groups (pamidronate, QIsm-F and tamoxifen), ranging from 0.01 µg/mL to 99 µg/mL for 72 h. Each treatment was carried out in triplicate. At the end of the treatment, 20 µL of freshly prepared MTT (5 mg/mL in PBS) (Nacalai Tescue, Japan) was added into each of the 96-wells plate followed by incubation for 4 h in a CO 2 incubator at 37 曟 . Then, formazon salts were dissolved with 100 µL dimethyl-sulphoxide (NacalaiTesque, Japan) and the absorbance was determined at 570 nm in ELISA micro plate reader. The graph of the percentage of viable cell versus log 10 concentration (µg/mL) of each fraction was plotted employing GraphPad Prism 6.0. The half maximal effective concentration (EC 50 )
was determined by the plotted graph.
Western blot
The total proteins were extracted at day 3 and day 7 of incubation with lysis buffer (Nacalai Tesque, Japan) for 20 min on ice. The protein samples were run on 10% SDS -PAGE gel electrophoresis at 100 V for 1 h for protein separation. The protein was then being transferred onto a polyvinylidene difluoride membrane using semidry transblot (BioRad, USA) at 15 V for 2 h. After transfer, the polyvinylidene difluoride membrane was blocked in 1% skim milk in tris-buffer saline with Tween-20 for 1 h followed by incubation with primary antibodies (against ß-actin 1:1 000, Runx2 1:400 and Osx 1:400 (Santa Cruz, USA) overnight at 4 曟 . The membrane were then matched with secondary antibody IgG HRP (1:1 000) (Santa Cruz, USA).
Immunocytochemistry
Immuno Images were viewed under fluoresence microscrope (Olympus, Japan) and captured by employing image analyser (Olympus, Japan).
Statistical analysis
Data were expressed as the mean±SEM of n=3 independent experiments. Statistical analysis was conducted by applying SPSS 
Results
EC 50 and effects of QIsm-F and combine treatment on cell viability
The EC 50 values of each treatment were established by using MTT assay ( Figure 1A ) with pamidronate (15.270 µg/mL), QIsm-F (11.600 µg/mL) and tamoxifen (1.568 µg/mL), respectively. The 
Effects of QIsm-F and combination of QIsm-F with pamidronate on Runx2 and Osx expression
Western blot analysis shows that the protein level of Runx2 ( Figure   2A ) and Osx ( Figure 2B ) increased significantly in a time dependant manner when treated with pamidronate, QIsm-F and combined The nuclei were stained with DAPI (blue staining).
濚 indicates cytoplasmic spreading; *indicates nuclear expression.
Discussion
As stated earlier, osteoporotic drug bisphosphonate mostly function as a resorptive inhibitor. The mechanism action of these drugs leads to decrease in important bone marker as well as exhibits negligible ability to enhance new synthesis of bone [34, 35] . Hence, it is necessary to investigate other potential anabolic agent that can helps to repair the imbalance of the bone remodelling process.
Natural anabolic agents from plant sources could be effective for use in the treatment of osteoporosis. Polyphenols, which is a major compound manifestation in Q. infectoria has been reported in the study's preliminary investigation to contribute to increasing in bone marker that plays a role in initial bone metabolism process [28] .
This experiment demonstrated detailed effects of QIsm-F isolated from Q. infectoria as well as the synergistic effects of combining As mentioned earlier, there has been several reported research on the ability of different polyphenols from different types of natural plants products contributing to osteoblast differentiation and proliferation [25] [26] [27] . This study incorporates crucial solvents interaction from chromatographic technique in order to obtain desired QIsm-F. The presence of polyphenol in isolated QIsm-F was observed as black spot on thin layer chromatography plate as a results of Fecl 3 staining and similar R f values when compared to standard polyphenols (gallic acid and tannins).
Cell viability assay is an essential tool to measure the number of viable cultured cells in order to determine the cytotoxicity and cell viability effects produced by the given treatments to cells [36] . Combination treatment therapy between natural plants compounds with readily available drugs has been shown to exhibit synergistic effects in various diseases such as cancer; multiple myeloma [37] and prostate cancer [38] ; viral infection [39] , diabetic [40] and many more.
The process of bone remodelling has been illustrated and well Throughout the years, the process of drug discovery utilizes the information obtained from natural product researches which are then being developed as well as incorporated towards discovering new drugs by combining the chemical structure with existing drug [43] .
Hence, it tends to be authentic that the data obtained from this research could be used to develop and adapt for discovery of new improved osteoporotic drug with minimal risk of side effects to human.
The effect of Q. infectoria as astringent, antidiabetic, antitremorine and local anaesthetic are well documented, nevertheless its effect on bone cells and associated disease are relatively still scarce. This research shows conclusive evidence that combination of these two agents acts synergistically by up-regulating both Runx2 and Osx marker via smad signalling pathway. Overall, the paper concluded that combination treatment between QIsm-F and pamidronate is effective treatment candidate for bone associated disease particularly osteoporosis than individual treatments; at the same time helps to improve the efficiency of osteoporotic drug pamidronate acting on bone forming cell.
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